CORP — CORPORATE / INDUSTRY

Pfizer Investigator Sponsored Research

Pfizer

Award

Funding and/or drug, project-based

Deadline

System migration ongoing — application windows still unposted as of Aug 28, 2026

Award type

Cash grant

Focus

Preclinical & therapeutics · Clinical research

Funding and/or drug for investigator-sponsored preclinical and clinical studies involving a Pfizer asset, plus general research projects. Rare-disease areas include ATTR cardiac amyloidosis and rare cardiomyopathy (tafamidis).

Why it's in this index

Pfizer has no active rare-DCM asset, so a BTHS proposal would need to connect to the rare-cardiomyopathy areas — heart-failure phenotyping methodology, for example — rather than to a BTHS therapeutic.

Who can apply

Qualified researchers at eligible institutions; country lists apply per therapeutic area.

How to apply

Via the Pfizer ISR portal (pfizer.com/ISR); applications are reviewed in batched cycles published on the site, with contracting targeted within 60 days of approval.

Links & downloads

Pfizer ISR ↗Rare disease areas ↗